InsiderTrades

Form 4 for MGX Metagenomi Therapeutics, Inc.

Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-09 · accession 0001209191-24-003423 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-15 2024-02-09+ MGX Novo Holdings A/S 10% P - Purchase $14.47 +900.0K 100.0K New +$13.03M
D 2024-02-15 2024-02-13 MGX Novo Holdings A/S 10% C - Cnv Deriv — +839.2K 939.2K +839% —
DM 2024-02-15 2024-02-13 MGX Novo Holdings A/S 10% C - Cnv Deriv — -839.2K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common COMMON STOCK 2024-02-13 P A 800,000 $15.00 1,739,175 D — — (F2) Represents a purchase from the underwriters in the Issuer's initial public offering.
2 Common COMMON STOCK 2024-02-09 P A 100,000 $10.25 100,000 D — —
3 Common COMMON STOCK 2024-02-13 C A 839,175 — 939,175 D — — (F1) Each share of Series B Preferred Stock and Series B-1 Preferred Stock converted into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.
4 Derivative SERIES B PREFERRED STOCK 2024-02-13 C D 147,415 — 0 D — · — to — 147,415 COMMON STOCK (F1) Each share of Series B Preferred Stock and Series B-1 Preferred Stock converted into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.
5 Derivative SERIES B-1 PREFERRED STOCK 2024-02-13 C D 691,760 — 0 D — · — to — 691,760 COMMON STOCK (F1) Each share of Series B Preferred Stock and Series B-1 Preferred Stock converted into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.